IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1

Historical Portfolio Holders from Q3 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Debt / NOTE 1.500% 6/1
Principal, excl. options Q1 2024
197 M
Holdings value Q1 2024
$201 M
Value change Q1 2024
-$4.54 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
26
Number of buys Q1 2024
16
Number of sells Q1 2024
-15
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
-0.001%
CUSIP
46333XAH1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q1 $197 M $201 M -$4.54 M $1.01 26
2023 Q4 $198 M $215 M -$57.8 M $1.08 23
2023 Q3 $254 M $235 M +$47.1 M $0.98 21
2023 Q2 $195 M $199 M -$3.82 M $1.02 17
2023 Q1 $199 M $200 M +$3.86 M $1.00 23
2022 Q4 $193 M $212 M +$3.26 M $1.09 25
2022 Q3 $172 M $168 M -$19 M $1.02 23
2022 Q2 $191 M $198 M -$2.93 M $1.08 20
2022 Q1 $194 M $219 M -$1.59 M $1.18 19
2021 Q4 $187 M $204 M -$9.01 M $1.14 18
2021 Q3 $198 M $243 M +$25.8 M $1.21 19
2021 Q2 $177 M $216 M +$8.63 M $1.20 18
2021 Q1 $170 M $196 M -$3.4 B $1.13 17
2020 Q4 $174 M $189 M +$1.15 M $1.13 17
2020 Q3 $167 M $164 M +$164 M $0.98 17